These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

79 related articles for article (PubMed ID: 324332)

  • 1. [Critical study of the treatment of lupic nephropathies].
    Mery JPh
    Ann Med Interne (Paris); 1977 Jan; 128(1):9-15. PubMed ID: 324332
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Systemic lupus erythematosus and end-stage chronic renal insufficiency. Therapeutic perspectives].
    Font J; Campistol JM
    Med Clin (Barc); 1989 Apr; 92(15):573-6. PubMed ID: 2666771
    [No Abstract]   [Full Text] [Related]  

  • 3. [Secondary glomerular nephropathies].
    Lesavre P
    Rev Prat; 2003 Nov; 53(18):2039-48. PubMed ID: 15008219
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Frequency of recurrent lupus nephritis among ninety-seven renal transplant patients during the cyclosporine era.
    Stone JH; Millward CL; Olson JL; Amend WJ; Criswell LA
    Arthritis Rheum; 1998 Apr; 41(4):678-86. PubMed ID: 9550477
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Correlation among WHO classes, histomorphologic patterns of glomerulonephritis and glomerular immune deposits in SLE.
    Ferluga D; Jerse M; Vizjak A; Hvala A; Rozman B; Kos-Golja M; Bren AF
    Wien Klin Wochenschr; 2000 Aug; 112(15-16):692-701. PubMed ID: 11020959
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Treatment of diffuse glomerulonephritis in systemic lupus erythematosus with a combination of anticoagulants, corticosteroids and immunosuppressors].
    Belovezhdov N
    Vutr Boles; 1985; 24(1):40-9. PubMed ID: 4024608
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Course of nephropathy in systemic lupus erythematosus . Influence of the treatment on clinical symptoms, renal function and histology].
    Zech P; Richard P; Blanc-Brunat N; Labeeuw M; Colon S; Pozet N; Dupont E; Fries D; Traeger J
    J Urol Nephrol (Paris); 1972 Dec; 78(12):987-93. PubMed ID: 4540960
    [No Abstract]   [Full Text] [Related]  

  • 8. Immunosuppressive treatment of the glomerulonephritis of systemic lupus.
    Faedda R; Palomba D; Satta A; Pirisi M; Tanda F; Bartoli E
    Clin Nephrol; 1995 Dec; 44(6):367-75. PubMed ID: 8719548
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nonlupus nephritides in patients with systemic lupus erythematosus: a comprehensive clinicopathologic study and review of the literature.
    Baranowska-Daca E; Choi YJ; Barrios R; Nassar G; Suki WN; Truong LD
    Hum Pathol; 2001 Oct; 32(10):1125-35. PubMed ID: 11679948
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Posttransplantation glomerulonephritis: risk factors associated with kidney allograft loss.
    Ostrowska J; Pazik J; Lewandowski Z; Mróz A; Perkowska-Ptasińska A; Durlik M
    Transplant Proc; 2007 Nov; 39(9):2751-3. PubMed ID: 18021977
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Lupus nephropathy. Treatment with the indomethacin-hydroxychloroquine combination and comparison with corticoids].
    Conte JJ; Mignon-Conte MA; Fournie GJ
    Nouv Presse Med; 1975 Jan; 04(2):91-5. PubMed ID: 1138230
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Critical reflections on treatment of lupic nephropathy: comparative study of the action of corticoids, synthetic antimalarial-indomethacin combination and heparin].
    Conte J; Mignon-Conte M; Suc JM
    J Urol Nephrol (Paris); 1973; 79(4):332-50. PubMed ID: 4720125
    [No Abstract]   [Full Text] [Related]  

  • 13. [Development and long term prognosis of lupus erythematosus (apropos of 124 cases)].
    Godeau P; Betourne C; Piette JC; Herreman G; Wechsler B; Levy R
    Ann Med Interne (Paris); 1977 Jan; 128(1):17-30. PubMed ID: 855968
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Lupus nephritis: retrospective analysis of the course of the disease].
    Djukanović L; Pavlović S; Blagojević R; Dimitrijević J; Stojsic T; Ratković M; Kazić K; Lezaić V; Naumović R
    Srp Arh Celok Lek; 2002 Aug; 130 Suppl 3():26-31. PubMed ID: 12583310
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Changing histopathology patterns in lupus nephropathy.
    Mahajan SK; Ordónez NG; Spargo BH; Katz AI
    Clin Nephrol; 1978 Jul; 10(1):1-8. PubMed ID: 699393
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Therapy of systemic lupus erythematosus].
    Marmont A
    Recenti Prog Med; 1966 Jun; 40(6):473-523. PubMed ID: 6014403
    [No Abstract]   [Full Text] [Related]  

  • 17. [Comparative evaluation of the effectiveness of diverse variants of drug therapy in chronic glomerulonephritis].
    Popova LA
    Ter Arkh; 1979; 51(1):77-83. PubMed ID: 432837
    [No Abstract]   [Full Text] [Related]  

  • 18. Clinical and morphological prognostic factors in membranous nephropathy: significance of focal segmental glomerulosclerosis.
    Dumoulin A; Hill GS; Montseny JJ; Meyrier A
    Am J Kidney Dis; 2003 Jan; 41(1):38-48. PubMed ID: 12500220
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Systemic lupus erythematosus V: lupus nephritis.
    Blotzer JW
    Md State Med J; 1983 Nov; 32(11):851-6. PubMed ID: 6361395
    [No Abstract]   [Full Text] [Related]  

  • 20. Immunofluorescent microscopic findings in glomerulonephritis.
    Tabassum S; Rahman KM; Mamun KZ; Ahmed AN; Islam KM; Rahman H
    Bangladesh Med Res Counc Bull; 1997 Dec; 23(3):77-81. PubMed ID: 9621476
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.